Newsletter Archive

As we expand our knowledge in the ever-growing field of drug toxicology, Friends Lab passes on its knowledge to current clients via a Periodic Newsletter. Some of our more recent and most asked for articles are contained here for your research and interest. If you have a topic idea or question regarding this material, drop us an e-mail.

The Monsters in the Street: GBH/Liquid Ecstasy
There is another lethal drug out there that is rearing its ugly head. It is called GHB or Gamma Hydroxybutyrate. Its street names are "GBH (Grievous Bodily Harm," "liquid ecstasy" and "Somatomax PM." The effects of this new drug have played part in the deaths of a 17-year-old high school student in Texas, as well as a professional wrestler in Ocean City, MD.
"Date-Rape" Drug: Rohypnol (Flunitrazepam)
DEA toughens penalties as use of Rohypnol rises among teens, addicts and would-be rapists. Within three months the DEA will put the "date-rape" drug Rohypnol in the same category as heroin and LSD to combat a sharp rise in smuggling, trafficking and possession.
Quinine Use and Detection
Describing the history of quinine introduction to heroin and the science of using quinine to detect heroin abuse in drug testing. Quinine is also available in non-drug forms making its detection as a marker for heroin more complicated. Included in this article is a listing of common drugs and commercial items containing quinine but not related to heroin abuse.
Methadone Use and Detection
Methadone is a commonly used drug treatment alternative to drugs of abuse, but its use must be strictly monitored as it is a powerful narcotic analgesic. This article explains the origins of Methadone and the possibilities and complications alternative drug testing methodologies pose.
Oxycodone Use and Detection
Oxycodone abuse has been an ongoing problem since the 1960's. A derivative of codeine, it is an effective analgesic for chronic pain and cancer patients, but has become a popular drug of abuse in recent years. This article delves into the effective uses of oxycodone, the current state of oxycodone abuse and the unique challenges drug testing laboratories have in properly screening for presence of oxycodone.